Therefore and considering that the clinical presentation, morphologic appearance and immunohistochemical profile of these MYC protein negative/MYCN protein-positive MYC-translocated tumors is not different from MYC protein-positive BL we think that this does not affect the diagnostic work-up as such cases might be easily diagnosed as BL based on current WHO criteria13. This evidence concerns the gene MYC and Burkitt lymphoma.